Evolution of HER2-positive mammary carcinoma: HER2 loss reveals claudin-low traits in cancer progression
Abstract HER2-positive breast cancers may lose HER2 expression in recurrences and metastases. In this work, we studied cell lines derived from two transgenic mammary tumors driven by human HER2 that showed different dynamics of HER2 status. MamBo89HER2 stable cell line displayed high and stable HER2...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Nature Publishing Group
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/b560bd2ffc044642b16dd92b9b06a0fa |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|